Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by dstotson Jun 03, 2020 9:32am
173 Views
Post# 31105782

$ and sense

$ and sense
Although I am disappointed that they had to do a placement  at 7 cents. After seeing the numbers in the prospectus i am encouraged. They clearly state that they have 250,000+ orders and that they are capable of 1000 tests per day (need equipment and people to perform them). We all knew that money was tight so in order to meet those test volumes they needed cash fast. With potentially $8 million they should be able to easily process all the tests that come their way and receive revenues of 18 to 34 million i think it said. If you take the median at $25ish million and add another 10 million later  from the 9 cent warrants, the company should no longer have to raise capital. So Covid is the catalyst that changes the coarse of this company. If covid 19 had not happened it is pretty clear SZLS would be bankrupt.
Covid looks like it is going to be with us until a vaccine or a high quality therapuetic is developed. We may have a year, maybe more, maybe less, who knows? As this virus plays out the cancer screening business must get traction or a year or two down the road this company is back in the same place but won't be able to raise money.
The thing we need to see is those test numbers and the revenues, but $25 million in revenue over 450 million shares is 5 cents of revenus/share. If the earnings are say 3 cents/share (60% margin) and we traded at a PE of 15 we might get a 45 cent stock price. If the revenues come fast maybe we get a bit of a momentum bump as well and trade at 20X = 60 cents
Looks like I talked myself into holding for another 6 months.
<< Previous
Bullboard Posts
Next >>